Dextera Surgical Inc. (NASDAQ:DXTR) gapped down prior to trading on Monday . The stock had previously closed at $0.36, but opened at $0.36. Dextera Surgical shares last traded at $0.35, with a volume of 4,952,902 shares trading hands.

Several equities research analysts recently issued reports on DXTR shares. Zacks Investment Research cut Dextera Surgical from a “hold” rating to a “sell” rating in a research note on Tuesday, May 9th. Wedbush lowered their price target on shares of Dextera Surgical from $3.50 to $0.70 and set an “outperform” rating for the company in a report on Wednesday, July 12th. Finally, Ladenburg Thalmann Financial Services began coverage on shares of Dextera Surgical in a report on Wednesday, August 16th. They set a “buy” rating and a $0.80 price target for the company.

The firm’s market capitalization is $5.90 million. The firm has a 50 day moving average price of $0.28 and a 200 day moving average price of $0.57.

Dextera Surgical (NASDAQ:DXTR) last announced its quarterly earnings results on Tuesday, August 8th. The medical instruments supplier reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by $0.29. The company had revenue of $1.05 million for the quarter, compared to the consensus estimate of $1.03 million. Analysts predict that Dextera Surgical Inc. will post ($0.24) earnings per share for the current year.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Perkins Capital Management Inc. purchased a new position in shares of Dextera Surgical during the second quarter valued at about $100,000. Broadfin Capital LLC increased its position in shares of Dextera Surgical by 64.7% during the second quarter. Broadfin Capital LLC now owns 987,520 shares of the medical instruments supplier’s stock valued at $296,000 after buying an additional 388,080 shares during the period. Finally, Virtu KCG Holdings LLC increased its position in shares of Dextera Surgical by 1,380.6% during the second quarter. Virtu KCG Holdings LLC now owns 369,918 shares of the medical instruments supplier’s stock valued at $111,000 after buying an additional 344,933 shares during the period. Institutional investors own 7.78% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This report was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at https://www.dailypolitical.com/2017/09/06/dextera-surgical-inc-dxtr-shares-gap-down-to-0-36-2.html.

Dextera Surgical Company Profile

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.